GE HealthCare Technologies Inc. (NASDAQ:GEHC) Announces Quarterly Dividend of $0.04

GE HealthCare Technologies Inc. (NASDAQ:GEHC - Get Free Report) declared a quarterly dividend on Monday, November 25th,Wall Street Journal reports. Investors of record on Tuesday, January 14th will be paid a dividend of 0.035 per share on Friday, February 14th. This represents a $0.14 annualized dividend and a yield of 0.17%. The ex-dividend date of this dividend is Tuesday, January 14th. This is a boost from GE HealthCare Technologies's previous quarterly dividend of $0.03.

GE HealthCare Technologies has a dividend payout ratio of 3.0% meaning its dividend is sufficiently covered by earnings. Equities analysts expect GE HealthCare Technologies to earn $4.67 per share next year, which means the company should continue to be able to cover its $0.14 annual dividend with an expected future payout ratio of 3.0%.

GE HealthCare Technologies Stock Up 0.3 %

Shares of GEHC traded up $0.22 during trading hours on Monday, hitting $82.66. The stock had a trading volume of 5,268,876 shares, compared to its average volume of 3,089,252. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98. GE HealthCare Technologies has a 1-year low of $66.39 and a 1-year high of $94.55. The firm has a 50 day simple moving average of $88.35 and a 200-day simple moving average of $83.62. The firm has a market capitalization of $37.76 billion, a P/E ratio of 22.65, a price-to-earnings-growth ratio of 2.95 and a beta of 1.24.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share for the quarter, beating analysts' consensus estimates of $1.06 by $0.08. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The company had revenue of $4.86 billion for the quarter, compared to analyst estimates of $4.87 billion. During the same quarter last year, the company earned $0.99 earnings per share. The company's revenue for the quarter was up .9% on a year-over-year basis. Sell-side analysts predict that GE HealthCare Technologies will post 4.3 EPS for the current fiscal year.

Insider Buying and Selling at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of the stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total transaction of $309,338.96. Following the sale, the chief executive officer now owns 24,298 shares of the company's stock, valued at approximately $2,101,291.04. This trade represents a 12.83 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.27% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the company. Stifel Nicolaus lifted their target price on GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a "buy" rating in a report on Monday, September 30th. Evercore ISI lifted their target price on GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an "outperform" rating in a report on Tuesday, October 1st. Redburn Atlantic raised GE HealthCare Technologies to a "strong-buy" rating in a report on Thursday, August 1st. BTIG Research raised GE HealthCare Technologies from a "neutral" rating to a "buy" rating and set a $100.00 target price for the company in a report on Wednesday, September 18th. Finally, Wells Fargo & Company lifted their target price on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an "overweight" rating in a report on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating, eight have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, GE HealthCare Technologies has a consensus rating of "Moderate Buy" and a consensus target price of $94.36.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.